|
|
||||||||
Ann Thorac Surg 1988;45:370-379
© 1988 The Society of Thoracic Surgeons
From the Departments of Surgery, Medicine, and Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA
* Address reprint requests to Dr. Martini, 1275 York Ave, New York, NY 10021.
We have defined "clinical N2" disease in non-small cell lung cancer to mean the presence of enlarged metastatic mediastinal nodes evident on plain chest roentgenograms or widening of the carina at bronchoscopy. Forty-one patients with non-small cell carcinoma of the lung and clinical N2 M0 disease presumed operable received 2 to 3 cycles of high-dose cisplatin with vindesine (or vinblastine sulfate) with or without mitomycin-C. Following chemotherapy, 30 patients (73%) had a major radiographic response. Of these patients, 28 had thoracotomy, and 21 (75%) of them had complete resection of the disease, 8 of whom had total sterilization of the tumor proven histologically. An additional 4 patients had limited microscopic foci of residual tumor either in lung or lymph nodes. Survival at 3 years from diagnosis was 34% for all patients, 40% for those who completed the combined treatment (chemotherapy and surgery), and 54% for those who had complete resection with a median follow-up of 44 months and a median survival not yeat attained.
This article has been cited by other articles:
![]() |
M. M. DeCamp Jr., S. Ashiku, and R. Thurer The Role of Surgery in N2 Non-Small Cell Lung Cancer Clin. Cancer Res., July 1, 2005; 11(13): 5033s - 5037s. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Machtay, J. H. Lee, J. P. Stevenson, J. B. Shrager, K. M. Algazy, J. Treat, and L. R. Kaiser Two commonly used neoadjuvant chemoradiotherapy regimens for locally advanced stage III non-small cell lung carcinoma: Long-term results and associations with pathologic response J. Thorac. Cardiovasc. Surg., January 1, 2004; 127(1): 108 - 113. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Galetta, A. Cesario, S. Margaritora, V. Porziella, G. Macis, R. M. D'Angelillo, L. Trodella, S. Sterzi, and P. Granone Enduring challenge in the treatment of nonsmall cell lung cancer with clinical stage IIIB: results of a trimodality approach Ann. Thorac. Surg., December 1, 2003; 76(6): 1802 - 1809. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Nagai, R. Tsuchiya, T. Mori, H. Tada, Y. Ichinose, T. Koike, and H. Kato A randomized trial comparing induction chemotherapy followed by surgery with surgery alone for patients with stage IIIA N2 non-small cell lung cancer (JCOG 9209) J. Thorac. Cardiovasc. Surg., February 1, 2003; 125(2): 254 - 260. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Cyjon, M. Nili, G. Fink, M. R. Kramer, E. Fenig, J. Sandbank, A. Sulkes, and E. Rakowsky Advanced non-small cell lung cancer: induction chemotherapy and chemoradiation before operation Ann. Thorac. Surg., August 1, 2002; 74(2): 342 - 347. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Akhurst, R. J. Downey, M. S. Ginsberg, M. Gonen, M. Bains, R. Korst, R. J. Ginsberg, V. W. Rusch, and S. M. Larson An initial experience with FDG-PET in the imaging of residual disease after induction therapy for lung cancer Ann. Thorac. Surg., January 1, 2002; 73(1): 259 - 266. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Margaritora, A. Cesario, D. Galetta, A. D'Andrilli, G. Macis, G. Mantini, L. Trodella, and P. Granone Ten year experience with induction therapy in locally advanced non-small cell lung cancer (NSCLC): is clinical re-staging predictive of pathological staging? Eur J Cardiothorac Surg, June 1, 2001; 19(6): 894 - 898. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Bunn Jr, J. Mault, and K. Kelly Adjuvant and Neoadjuvant Chemotherapy for Non-Small Cell Lung Cancer : A Time for Reassessment? Chest, April 1, 2000; 117(2009): 119S - 122S. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. M. HARROW, W. ABI-SALEH, J. BLUM, T. HARKIN, S. GASPARINI, D. J. ADDRIZZO-HARRIS, A. C. ARROLIGA, G. WIGHT, and A. C. MEHTA The Utility of Transbronchial Needle Aspiration in the Staging of Bronchogenic Carcinoma Am. J. Respir. Crit. Care Med., February 1, 2000; 161(2): 601 - 607. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Stuschke, W. Eberhardt, C. Pottgen, G. Stamatis, H. Wilke, G. Stuben, F. Stoblen, H. H. Wilhelm, H. Menker, H. Teschler, et al. Prophylactic Cranial Irradiation in Locally Advanced Non-Small-Cell Lung Cancer After Multimodality Treatment: Long-Term Follow-Up and Investigations of Late Neuropsychologic Effects J. Clin. Oncol., September 1, 1999; 17(9): 2700 - 2700. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. A. Rendina, F. Venuta, T. D. Giacomo, A. M. Ciccone, G. Ruvolo, G. F. Coloni, C. Ricci, and S. G. A. Patterson INDUCTION CHEMOTHERAPY FOR T4 CENTRALLY LOCATED NON-SMALL CELL LUNG CANCER J. Thorac. Cardiovasc. Surg., February 1, 1999; 117(2): 225 - 233. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Akamatsu, M. Terashima, T. Koike, T. Takizawa, and Y. Kurita Staging of Primary Lung Cancer by Computed Tomography-Guided Percutaneous Needle Cytology of Mediastinal Lymph Nodes Ann. Thorac. Surg., August 1, 1996; 62(2): 352 - 355. [Abstract] [Full Text] |
||||
![]() |
J. R. Izbicki, W. T. Knoefel, B. Passlick, M. Habekost, O. Karg, and O. Thetter RISK ANALYSIS AND LONG-TERM SURVIVAL IN PATIENTS UNDERGOING EXTENDED RESECTION OF LOCALLY ADVANCED LUNG CANCER J. Thorac. Cardiovasc. Surg., August 1, 1995; 110(2): 386 - 395. [Abstract] [Full Text] |
||||
![]() |
P. Macchiarini, A. R. Chapelier, I. Monnet, J.-M. Vannetzel, J.-L. Rebischung, J. Cerrina, F. Parquin, F. Le Roy Ladurie, B. Lenot, and P. G. Dartevelle Extended operations after induction therapy for stage IIIb (T4) non-small cell lung cancer Ann. Thorac. Surg., April 1, 1994; 57(4): 966 - 973. [Abstract] [PDF] |
||||
![]() |
N. Martini, M. G. Kris, B. J. Flehinger, R. J. Gralla, M. S. Bains, M. E. Burt, R. Heelan, P. M. McCormack, K. M. W. Pisters, J. R. Rigas, et al. Preoperative chemotherapy for stage IIIa (N2) lung cancer: The Sloan-Kettering experience with 136 patients Ann. Thorac. Surg., June 1, 1993; 55(6): 1365 - 1374. [Abstract] [PDF] |
||||
![]() |
F. A. Shepherd Induction chemotherapy for locally advanced non-small cell lung cancer Ann. Thorac. Surg., June 1, 1993; 55(6): 1585 - 1592. [Abstract] [PDF] |
||||
![]() |
W. C. Fowler, C. J. Langer, W. J. Curran Jr, and S. M. Keller Postoperative complications after combined neoadjuvant treatment of lung cancer Ann. Thorac. Surg., April 1, 1993; 55(4): 986 - 989. [Abstract] [PDF] |
||||
![]() |
H. I. Pass, H. W. Pogrebniak, S. M. Steinberg, J. Mulshine, and J. Minna Randomized trial of neoadjuvant therapy for lung cancer: Interim analysis Ann. Thorac. Surg., June 1, 1992; 53(6): 992 - 998. [Abstract] [PDF] |
||||
![]() |
A. Y. Lin and D. C. Ihde Recent Developments in the Treatment of Lung Cancer JAMA, March 25, 1992; 267(12): 1661 - 1664. [Abstract] [PDF] |
||||
![]() |
J. Yashar, A. B. Weitberg, A. S. Glicksman, M. R. Posner, W. Feng, and H. J. Wanebo Preoperative chemotherapy and radiation therapy for stage IIIa carcinoma of the lung Ann. Thorac. Surg., March 1, 1992; 53(3): 445 - 448. [Abstract] [PDF] |
||||
![]() |
Y. Watanabe, J. Shimizu, M. Oda, Y. Hayashi, S. Watanabe, Y. Tatsuzawa, T. Iwa, M. Suzuki, and T. Takashima Aggressive surgical intervention in N2 non-small cell cancer of the lung Ann. Thorac. Surg., February 1, 1991; 51(2): 253 - 261. [Abstract] [PDF] |
||||
![]() |
L. P. Faber, C. F. Kittle, W. H. Warren, P. D. Bonomi, S. G. Taylor IV, S. Reddy, and M.-S. Lee Preoperative chemotherapy and irradiation for stage III non-small cell lung cancer Ann. Thorac. Surg., May 1, 1989; 47(5): 669 - 677. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |